Gentell Acquires ManukaMed

July 14, 2025

Gentell has acquired ManukaMed, a New Zealand-based manufacturer of Manuka honey–based wound dressings, and will rebrand the business as Gentell ManukaMed. The acquisition adds the only honey-based wound care product reimbursable by Medicare to Gentell’s portfolio, expands its manufacturing footprint (including ManukaMed’s U.S. HQ in Franklin, Tennessee and a Kansas City distribution center), and supports capability and geographic expansion into Australia and Southeast Asia.

Buyers
Gentell
Targets
ManukaMed
Industry
Medical Devices
Location
Wellington Region, New Zealand
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.